EW
Edwards Lifesciences Corp
NYSE: EW · HEALTHCARE · MEDICAL DEVICES
$81.22
-1.29% today
Updated 2026-04-29
Market cap
$46.83B
P/E ratio
43.90
P/S ratio
7.43x
EPS (TTM)
$1.85
Dividend yield
—
52W range
$72 – $88
Volume
5.0M
Edwards Lifesciences Corp (EW) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.04B | $1.09B | $1.24B | $1.32B | $1.45B | $1.68B | $1.90B | $2.05B | $2.32B | $2.49B | $2.96B | $3.44B | $3.72B | $4.35B | $4.39B | $5.23B | $5.38B | $6.00B | $5.44B | $6.07B |
| Revenue growth (YoY) | — | +5.2% | +13.4% | +6.8% | +9.5% | +16.0% | +13.2% | +7.7% | +13.6% | +7.4% | +18.8% | +15.9% | +8.4% | +16.8% | +0.9% | +19.3% | +2.9% | +11.6% | -9.4% | +11.5% |
| Cost of revenue | $383.30M | $381.30M | $408.90M | $399.10M | $410.10M | $460.80M | $506.80M | $543.90M | $631.20M | $684.30M | $805.80M | $882.90M | $922.10M | $1.16B | $1.10B | $1.23B | $1.17B | $1.38B | $1.12B | $1.33B |
| Gross profit | $653.70M | $709.80M | $828.80M | $922.30M | $1.04B | $1.22B | $1.39B | $1.50B | $1.69B | $1.81B | $2.16B | $2.55B | $2.80B | $3.19B | $3.29B | $4.01B | $4.22B | $4.63B | $4.32B | $4.74B |
| Gross margin | 63.0% | 65.1% | 67.0% | 69.8% | 71.7% | 72.5% | 73.3% | 73.4% | 72.8% | 72.6% | 72.8% | 74.3% | 75.2% | 73.4% | 74.9% | 76.6% | 78.3% | 77.0% | 79.5% | 78.1% |
| R&D | $114.20M | $122.30M | $139.20M | $175.50M | $204.40M | $246.30M | $291.30M | $323.00M | $346.50M | $383.10M | $442.20M | $552.60M | $622.20M | $752.70M | $760.70M | $903.10M | $945.20M | $1.07B | $1.05B | $1.08B |
| SG&A | $376.00M | $418.00M | $480.60M | $508.80M | $550.00M | $642.40M | $705.30M | $745.60M | $858.00M | $850.70M | $904.70M | $984.70M | $1.09B | $1.24B | $1.23B | $1.49B | $1.57B | $1.76B | $1.79B | $2.09B |
| Operating income | $163.50M | $169.50M | $209.00M | $238.00M | $282.50M | $329.10M | $396.70M | $433.00M | $487.20M | $575.90M | $815.50M | $1.01B | $1.09B | $1.20B | $1.30B | $1.61B | $1.70B | $1.53B | $1.38B | $1.64B |
| Operating margin | 15.8% | 15.5% | 16.9% | 18.0% | 19.5% | 19.6% | 20.9% | 21.2% | 21.0% | 23.1% | 27.5% | 29.4% | 29.3% | 27.6% | 29.5% | 30.8% | 31.6% | 25.5% | 25.3% | 27.0% |
| EBITDA | $239.60M | $213.70M | $227.20M | $296.70M | $327.10M | $344.70M | $452.80M | $589.80M | $1.23B | $706.60M | $827.10M | $1.14B | $872.20M | $1.31B | $1.07B | $1.89B | $1.96B | $1.53B | $1.72B | $1.43B |
| EBITDA margin | 23.1% | 19.6% | 18.4% | 22.5% | 22.6% | 20.5% | 23.8% | 28.8% | 53.1% | 28.3% | 27.9% | 33.2% | 23.4% | 30.1% | 24.5% | 36.1% | 36.4% | 25.5% | 31.7% | 23.6% |
| EBIT | $182.80M | $158.90M | $171.60M | $238.00M | $270.60M | $286.70M | $395.50M | $521.10M | $1.17B | $640.80M | $755.90M | $1.06B | $794.80M | $1.19B | $938.90M | $1.73B | $1.79B | $1.53B | $1.57B | $1.27B |
| Interest expense | $10.50M | $9.10M | $7.20M | $1.10M | $2.40M | $3.10M | $4.40M | $5.80M | $21.60M | $18.40M | $18.00M | $23.20M | $33.40M | $27.30M | $22.20M | $24.80M | $26.20M | $17.60M | $19.80M | $20.40M |
| Income tax | $41.80M | $36.80M | $35.50M | $75.30M | $50.20M | $46.90M | $97.90M | $123.60M | $332.90M | $127.50M | $168.40M | $451.30M | $39.20M | $119.60M | $93.30M | $198.90M | $245.50M | $198.70M | $152.10M | $216.90M |
| Effective tax rate | 24.3% | 24.6% | 21.6% | 24.7% | 18.7% | 16.5% | 25.0% | 24.0% | 29.1% | 20.5% | 22.8% | 42.0% | 5.1% | 10.3% | 10.2% | 11.7% | 13.9% | 12.4% | 3.5% | 16.8% |
| Net income | $130.50M | $113.00M | $128.90M | $229.10M | $218.00M | $236.70M | $293.20M | $391.70M | $811.10M | $494.90M | $569.50M | $622.10M | $722.20M | $1.05B | $823.40M | $1.50B | $1.52B | $1.40B | $4.17B | $1.07B |
| Net income growth (YoY) | — | -13.4% | +14.1% | +77.7% | -4.8% | +8.6% | +23.9% | +33.6% | +107.1% | -39.0% | +15.1% | +9.2% | +16.1% | +45.0% | -21.3% | +82.5% | +1.3% | -7.9% | +197.7% | -74.3% |
| Profit margin | 12.6% | 10.4% | 10.4% | 17.3% | 15.1% | 14.1% | 15.4% | 19.1% | 34.9% | 19.8% | 19.2% | 18.1% | 19.4% | 24.1% | 18.8% | 28.7% | 28.3% | 23.4% | 76.7% | 17.7% |